Regulatory & Reimbursement
Breakthrough Tips for Innovators from Former FDA Program Lead
Often-overlooked regulatory and related reimbursement considerations for device companies pursuing the popular Breakthrough Device pathway from John Doucet, former Policy Lead for the Breakthrough Device Program at FDA.
Read Article